Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for ...

Henderson was diagnosed with peripartum cardiomyopathy, an uncommon type of heart failure that can happen toward the end of ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

These properties make SA invaluable in biomolecule capture and enrichment in analytical applications such as ELISA, protein ...

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...

Tau protein is essential for microtubule stability and neuronal function. The protein’s disfunction is linked to several ...

Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder marked primarily by β-amyloid (Aβ) deposition and abnormal ...

ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...

Following news on social media can enhance knowledge, belief accuracy, and trust, suggesting a path to a more informed ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

ACROBiosystems has developed a series of specialized proteases for the screening and validation of ADC linkers, focusing on ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...